Business Wire

CrowdStrike Introduces New Automated Threat Analysis Solution to Deliver Predictive Security

16.4.2018 15:00:00 EEST | Business Wire | Press release

Share

CrowdStrike® Inc., the leader in cloud-delivered endpoint protection, today announced that it has expanded the capabilities of the CrowdStrike Falcon® platform by introducing a new threat analysis subscription module, CrowdStrike Falcon X™.

In today's threat environment, it is critical to add predictive security controls by learning from your encounters with cyber threat actors. However, most security teams lack the resources or the expertise to effectively adopt this emerging approach. As a result, they are stuck in a reactive state and can’t get ahead of future threats. CrowdStrike Falcon X solves this problem by automating threat analysis and delivering customized and actionable intelligence so that organizations can implement proactive defenses.

Built on the CrowdStrike Falcon platform, CrowdStrike Falcon X brings endpoint protection to the next level by combining malware sandboxing, malware search and threat intelligence into an integrated solution that can perform comprehensive threat analysis in seconds instead of hours or days. The output of this analysis is a unique combination of customized indicators of compromise (IOCs) and threat intelligence designed to help prevent against threats your organization faces now and in the future. Falcon X is the only solution that produces IOCs for both the threat that was actually encountered in your organization and all of its known variants, and immediately shares them with other security tools like firewalls, gateways and security orchestration tools via API. CrowdStrike Falcon X also provides integrated threat intelligence alongside its security alerts to accelerate incident research, streamline the investigative process and drive better security responses.

With this Spring Platform release, CrowdStrike empowers customers of all sizes to better understand the threats they face and improve the efficacy of their other security investments with actionable and customized intelligence. CrowdStrike Falcon X allows customers to finally pivot from a reactive security posture to a proactive one, mitigating their risk exposure and enhancing their ability to stop breaches.

“Most incident response teams have to manually analyze the threats they face with limited visibility into the targeted threat intelligence behind them. With CrowdStrike Falcon X, we elevate customers’ abilities to perform better analysis when a threat is detected and correlate it with strategic and tactical intelligence quickly, cutting down investigation time from hours and even days to seconds. Through this automation, we help smaller teams achieve a level of protection that would normally be out of reach, and we help larger teams make each of their analysts more effective. Falcon X provides all security teams with more comprehensive threat analysis to inform effective, prioritized response options, making remediation efforts more strategic and efficient,” said Dmitri Alperovitch, CrowdStrike’s co-founder and chief technology officer.

CrowdStrike Falcon X stands out with the following capabilities:

  • Automatic Threat Analysis — All files quarantined by CrowdStrike Falcon endpoint protection are automatically investigated by Falcon X. This automation drives breakthrough efficiency gains for security operations teams, elevates the capabilities of all security analysts and unlocks critical security functionality for organizations without a SOC.
  • Malware Analysis — Falcon X enables in-depth analysis of unknown and zero-day threats that goes far beyond traditional approaches. Powered by the Falcon Sandbox, it employs a unique combination of static, dynamic and fine-grained memory analysis to quickly identify the evasive threats other solutions miss.
  • Malware Search — Connects the dots between the malware found on your endpoints and related campaigns, malware families or threat actors. Falcon X searches CrowdStrike Falcon Search Engine, the industry's largest malware search engine for related samples and within seconds expands the analysis to include all files and variants, leading to a deeper understanding of the attack and an expanded set of IOCs to defend against future attacks.
  • Threat Intelligence Actor attribution exposes the motivation and the tools, techniques and procedures (TTPs) of the attacker. Practical guidance is provided to prescribe proactive steps against future attacks and stop actors in their tracks.
  • Customized Intelligence CrowdStrike Falcon X automatically produces intelligence specifically tailored for the threats you encounter in your environment. Customized IOCs are immediately shared with other security tools via API, streamlining and automating the protection workflow. Cyber threat intelligence related to the encountered attack is displayed alongside the alert, making it quick and easy for analysts to understand the threat and take action.

“CrowdStrike technology has proven to be a key security resource to help our team analyze cyber threats and prioritize the most critical malicious behavior for faster remediation,” said Edward Ganom, chief information security officer at the Commercial Bank in Qatar. “CrowdStrike Falcon has proven time and time again its ability to accelerate the threat detection and response process and integrate actionable intelligence to better protect our environment against cyberattacks.”

According to a Gartner Strategic Planning Assumption, by 2021, at least one company will publicly acknowledge a $1 billion revenue impact from a business outage resulting from a malware/ransomware attack. Gartner states, “To counteract this growth, companies will need not only to increase their proactive defenses, but also to speed up their time to react, repair damaged data and return systems to operational states. Holistic attack detection platforms that analyze data from endpoints, internal infrastructure and external resources become vital to decrease the time to detect and recover.”*

The CrowdStrike Falcon platform leverages machine learning and behavioral analytics, trained on processing over 100 billion security events a day, to enable reliable prevention, detection, mitigation and response to all threats, including malware-free intrusions. With the launch of Falcon X, customers can now prevent, detect, respond to and predict cyberthreats, all through one cloud-native platform.

1.Gartner, “Predicts 2018: Security and Risk Management Programs,” Rob McMillan, Jeffrey Wheatman, et al., 16 November 2017.

For more information about the CrowdStrike Spring Platform launch, read a blog by George Kurtz, CrowdStrike’s CEO, here.

Visit CrowdStrike during the RSA Conference 2018 at booth #941 Moscone South to see presentations and demos and meet with CrowdStrike security experts.

About CrowdStrike®

CrowdStrike is the leader in cloud-delivered endpoint protection. Leveraging artificial intelligence (AI), the CrowdStrike Falcon® platform offers instant visibility and protection across the enterprise and prevents attacks on endpoints on or off the network. CrowdStrike Falcon deploys in minutes to deliver actionable intelligence and real-time protection from Day One. It seamlessly unifies next-generation AV with best-in-class endpoint detection and response, backed by 24/7 managed hunting. Its cloud infrastructure and single-agent architecture take away complexity and add scalability, manageability, and speed.

CrowdStrike Falcon protects customers against all cyberattack types, using sophisticated signatureless AI and Indicator-of-Attack (IOA) based threat prevention to stop known and unknown threats in real time. Powered by the CrowdStrike Threat Graph™, Falcon instantly correlates over 100 billion security events a day from across the globe to immediately prevent and detect threats.

There’s much more to the story of how Falcon has redefined endpoint protection but there’s only one thing to remember about CrowdStrike: We stop breaches.

You can gain full access to CrowdStrike Falcon Prevent™ by starting your free trial here.

Learn more: https://www.crowdstrike.com/
Follow us: Blog | Twitter

© 2018 CrowdStrike, Inc. All rights reserved. CrowdStrike®, CrowdStrike Falcon®, CrowdStrike Threat Graph™, CrowdStrike Falcon Prevent™, Falcon Prevent™, CrowdStrike Falcon Insight™, Falcon Insight™, CrowdStrike Falcon Discover™, Falcon Discover™, CrowdStrike Falcon Intelligence™, Falcon Intelligence™, CrowdStrike Falcon DNS™, Falcon DNS™, CrowdStrike Falcon OverWatch™, Falcon OverWatch™, CrowdStrike Falcon Spotlight™ and Falcon Spotlight™ are among the trademarks of CrowdStrike, Inc. Other brands may be third-party trademarks.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

CrowdStrike, Inc.
Ilina Cashiola, 202-340-0517
Ilina.cashiola@crowdstrike.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release

Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye